Connection

Shari Lipner to Administration, Topical

Back to Details
This is a "connection" page, showing publications Shari Lipner has written about Administration, Topical.
Shari Lipner
Connection Strength
0.700
Administration, Topical
  1. Pharmacy costs of medications for the treatment of onychomycosis in the United States. J Am Acad Dermatol. 2019 07; 81(1):276-278.
    View in: PubMed
    Score: 0.175
  2. Optimizing topical therapy for onychomycosis: the importance of patient education. Cutis. 2018 Dec; 102(6):389-390.
    View in: PubMed
    Score: 0.173
  3. Planimetric Post-hoc Analysis of Women With Onychomycosis from Tavaborole 5% Phase III Studies: Evidence of Greater Improvements in Patients With >50% Baseline Infection. J Drugs Dermatol. 2018 Feb 01; 17(2):168-172.
    View in: PubMed
    Score: 0.163
  4. Over-the-counter and natural remedies for onychomycosis: do they really work? Cutis. 2016 Nov; 98(5):E16-E25.
    View in: PubMed
    Score: 0.150
  5. Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies. J Dermatolog Treat. 2018 Feb; 29(1):44-48.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.